These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12733139

  • 1. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
    Yamashita K, Upadhay S, Mimori K, Inoue H, Mori M.
    Cancer; 2003 May 15; 97(10):2412-9. PubMed ID: 12733139
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H, Triboulet JP, Kotelevets L, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E.
    Clin Cancer Res; 1998 Jun 15; 4(6):1375-82. PubMed ID: 9626453
    [Abstract] [Full Text] [Related]

  • 3. The differential expression of SPARC in esophageal squamous cell carcinoma.
    Che Y, Luo A, Wang H, Qi J, Guo J, Liu Z.
    Int J Mol Med; 2006 Jun 15; 17(6):1027-33. PubMed ID: 16685412
    [Abstract] [Full Text] [Related]

  • 4. SPARC is associated with gastric cancer progression and poor survival of patients.
    Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ.
    Clin Cancer Res; 2010 Jan 01; 16(1):260-8. PubMed ID: 20028745
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
    Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K.
    Clin Cancer Res; 2000 Mar 01; 6(3):1169-74. PubMed ID: 10741748
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO, Kagawa S.
    J Urol; 2001 Dec 01; 166(6):2495-9. PubMed ID: 11696817
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
    Rodríguez-Jiménez FJ, Caldés T, Iniesta P, Vidart JA, Garcia-Asenjo JL, Benito M.
    Oncol Rep; 2007 Jun 01; 17(6):1301-7. PubMed ID: 17487382
    [Abstract] [Full Text] [Related]

  • 8. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL, Warnecke-Eberz U, Xi H, Brabender J, Baldus SE, Bollschweiler E, Gutschow CA, Hölscher AH, Schneider PM.
    Oncol Rep; 2006 May 01; 15(5):1397-401. PubMed ID: 16596217
    [Abstract] [Full Text] [Related]

  • 9. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.
    Carcinogenesis; 2004 Dec 01; 25(12):2353-60. PubMed ID: 15333466
    [Abstract] [Full Text] [Related]

  • 10. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K, Sato N, Ohuchida K, Mizumoto K, Tanaka M.
    Anticancer Res; 2010 Mar 01; 30(3):867-71. PubMed ID: 20393008
    [Abstract] [Full Text] [Related]

  • 11. The clinical significance of MMP-1 expression in oesophageal carcinoma.
    Yamashita K, Mori M, Kataoka A, Inoue H, Sugimachi K.
    Br J Cancer; 2001 Jan 01; 84(2):276-82. PubMed ID: 11161388
    [Abstract] [Full Text] [Related]

  • 12. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD.
    Gynecol Oncol; 2008 Mar 15; 108(3):533-42. PubMed ID: 18177928
    [Abstract] [Full Text] [Related]

  • 14. The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease.
    Takahashi M, Nagaretani H, Funahashi T, Nishizawa H, Maeda N, Kishida K, Kuriyama H, Shimomura I, Maeda K, Hotta K, Ouchi N, Kihara S, Nakamura T, Yamashita S, Matsuzawa Y.
    Obes Res; 2001 Jul 15; 9(7):388-93. PubMed ID: 11445660
    [Abstract] [Full Text] [Related]

  • 15. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
    Shen LC, Chen YK, Hsue SS, Shaw SY.
    J Oral Pathol Med; 2010 Mar 15; 39(3):242-9. PubMed ID: 20070483
    [Abstract] [Full Text] [Related]

  • 16. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC.
    Ai Zheng; 2003 Sep 15; 22(9):968-73. PubMed ID: 12969531
    [Abstract] [Full Text] [Related]

  • 17. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 15; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 18. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H.
    Urology; 2004 Mar 15; 63(3):602-8. PubMed ID: 15028476
    [Abstract] [Full Text] [Related]

  • 19. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST.
    J Pathol; 2006 Dec 15; 210(4):459-68. PubMed ID: 17029219
    [Abstract] [Full Text] [Related]

  • 20. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
    Wu J, Zhang JR, Jiang XQ, Cao XG.
    Mol Med Rep; 2017 Sep 15; 16(3):3401-3406. PubMed ID: 28713937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.